Marta Waliszewska-Prosół
Marta Waliszewska-Prosół is an expert in Neurology at Wrocław Medical University (Poland). As of October 2026, ScienceLeadR ranks Marta Waliszewska-Prosół in the top 1% of experts worldwide for Headache, Migraine Disorders and Headache Disorders. Marta Waliszewska-Prosół has authored 138 publications, the most recent in 2026, and is an investigator in 3 clinical trials, 1 of them ongoing. SLR score: 644 (community average: 125). How the SLR is computed.
LeadR Profile
Neurology
Subspecialties: Neurosurgery - Biochemistry - Sleep Medicine Specialty
Main Topics
Publications and Clinical Studies
Profile data updated on
Organizations
Career arc: 2010 - 2026
Number : 138
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Migraine and Obesity: From Shared Mechanisms to Therapeutic Strategies. PMID 42853529 — glucagon-like peptide 1, weight gain, migraine disorders, obesity, therapeutics | Neurol Ther | 2026 | 0 |
| Airplane headache: a scoping review of mechanisms and reported therapeutic strategies. PMID 42779178 — headache, pain, pain management, migraine disorders, atmospheric pressure, therapeutics, headache disorders | Pain Manag | 2026 | 0 |
| OnabotulinumtoxinA for chronic migraine: A real-life multicenter study of 479 patients. PMID 42662157 — headache, treatment outcome, migraine disorders, therapeutics | Ther Adv Neurol Disord | 2026 | 0 |
| Dopaminergic Dysregulation in Migraine: From Hypothalamic A11 Dysfunction to a Systemic Biobehavioral Phenotype. PMID 42653268 — genes, neuroimaging, hypothalamus, phenotype, migraine disorders, dopamine, restless legs syndrome, attention deficit disorder with hyperactivity | Int J Mol Sci | 2026 | 0 |
| Interictal cognitive event-related potentials in migraine subtypes: association with neuropsychiatric symptoms. PMID 42591320 — comorbidity, sleep, migraine disorders, signs and symptoms | Front Neurol | 2026 | 0 |
Clinical Studies 3
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Real world Prospective Study on the Use of Anti CGRP Drugs in Migraine NCT07159750 — headache, genes, calcitonin gene-related peptide receptor antagonists, calcitonin gene-related peptide, pharmaceutical preparations, migraine disorders, receptors, calcitonin gene-related peptide, receptors, peptide, prospective studies, calcitonin | N/A | Recruiting | 2024 |
LeadR Networks
Main global connection map